Wealth Architects, LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
Wealth Architects, LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$212,874
-10.6%
9,828
-1.8%
0.04%
-19.1%
Q2 2022$238,000
+5.8%
10,005
+0.3%
0.05%
+23.7%
Q1 2022$225,000
-17.6%
9,975
-19.5%
0.04%
-28.3%
Q2 2021$273,000
-7.1%
12,390
+0.3%
0.05%
-17.2%
Q1 2021$294,000
-9.3%
12,356
-0.3%
0.06%
-14.7%
Q4 2020$324,000
+50.0%
12,391
-0.0%
0.08%
+27.1%
Q3 2020$216,000
+3.8%
12,394
+0.1%
0.06%
+1.7%
Q2 2020$208,000
+41.5%
12,3820.0%0.06%
+13.7%
Q1 2020$147,000
-1.3%
12,382
+0.6%
0.05%
+21.4%
Q4 2019$149,000
-33.5%
12,310
-22.4%
0.04%
-38.2%
Q3 2019$224,000
+20.4%
15,8600.0%0.07%
+17.2%
Q1 2019$186,000
-12.3%
15,8600.0%0.06%
-23.7%
Q4 2018$212,000
-4.5%
15,8600.0%0.08%
+10.1%
Q3 2018$222,000
-10.8%
15,860
+0.3%
0.07%
-14.8%
Q2 2018$249,000
-4.2%
15,8150.0%0.08%
-5.8%
Q1 2018$260,000
-9.1%
15,8150.0%0.09%
-8.5%
Q4 2017$286,000
-6.2%
15,8150.0%0.09%
-11.3%
Q3 2017$305,000
+64.0%
15,8150.0%0.11%
+53.6%
Q2 2017$186,000
+69.1%
15,815
+58.2%
0.07%
+56.8%
Q1 2017$110,000
+50.7%
10,0000.0%0.04%
+33.3%
Q4 2016$73,000
+12.3%
10,0000.0%0.03%
+10.0%
Q3 2016$65,000
+20.4%
10,0000.0%0.03%
+15.4%
Q2 2016$54,00010,0000.03%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,911,376$155,644,0006.95%
Parallel Advisors, LLC 1,944,319$47,014,0001.86%
TANAKA CAPITAL MANAGEMENT INC 39,289$885,0001.79%
S&T BANK/PA 508,546$11,452,0001.73%
Bridge City Capital, LLC 83,967$1,891,0000.88%
Birchview Capital, LP 50,000$1,126,0000.81%
Quantedge Capital Pte Ltd 113,012$2,545,0000.75%
FAS Wealth Partners, Inc. 289,625$6,522,0000.61%
AJ WEALTH STRATEGIES, LLC 396,029$8,919,0000.44%
TRUSTCORE FINANCIAL SERVICES, LLC 208,806$4,702,0000.41%
View complete list of CORCEPT THERAPEUTICS INC shareholders